{"id":77940,"date":"2018-06-12T12:34:00","date_gmt":"2018-06-12T12:34:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/"},"modified":"2018-06-12T12:34:00","modified_gmt":"2018-06-12T12:34:00","slug":"farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/","title":{"rendered":"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#8217;atenci\u00f3 a pacients amb c\u00e0ncer"},"content":{"rendered":"<p>\u00a0<br \/>\n\t<strong>Els farmac\u00e8utics han pogut aprofundir coneixements sobre com ajudar els pacients oncol\u00f2gics\u00a0<\/strong>en les diverses fases de la malaltia, des de la prevenci\u00f3 fins a l\u2019estat de supervivent<br \/>\n\tLa formaci\u00f3,\u00a0<strong>organitzada per primera vegada pel COF de Barcelona,\u00a0<\/strong>va comptar amb un\u00a0<strong>equip multidisciplinari -onc\u00f2legs, farmac\u00e8utics i metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i Equips de Suport (PADES)-\u00a0<\/strong>i els\u00a0<strong>alumnes\u00a0<\/strong>en van fer una\u00a0<strong>valoraci\u00f3 molt positiva<\/strong><\/p>\n<p>Els farmac\u00e8utics,\u00a0com a professionals sanitaris propers i de refer\u00e8ncia,<strong>\u00a0tenen un paper clau a l\u2019hora d\u2019ajudar al pacient amb c\u00e0ncer a millorar la qualitat de vida i l\u2019adher\u00e8ncia als tractaments.<\/strong>\u00a0Per tal de donar m\u00e9s eines a aquests professionals sanitaris, el\u00a0<strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) ha organitzat, per primera vegada,\u00a0<\/strong>un\u00a0<strong>curs centrat en l\u2019atenci\u00f3 farmac\u00e8utica a pacients oncol\u00f2gics,<\/strong>\u00a0amb la col\u00b7laboraci\u00f3 de la\u00a0Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC).<\/p>\n<p>La formaci\u00f3,\u00a0<strong>impartida per un equip multidisciplinari<\/strong>\u00a0&#8211;<strong>onc\u00f2legs<\/strong>,\u00a0<strong>farmac\u00e8utics\u00a0<\/strong>i\u00a0<strong>metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i Equips de Suport (PADES)-<\/strong>, va estar patrocinada per Janssen, Roche i Pfizer. Durant els tres dies que va durar, els<strong>\u00a077 farmac\u00e8utics que van assistir \u00a0van aprofundir coneixements sobre com abordar l\u2019actuaci\u00f3 farmac\u00e8utica en totes les etapes del pacient oncol\u00f2gic:<\/strong>\u00a0des de la\u00a0<strong>prevenci\u00f3<\/strong>, la\u00a0<strong>detecci\u00f3<\/strong>\u00a0i les\u00a0<strong>etapes interm\u00e8dies de tractament<\/strong>\u00a0<strong>actiu\u00a0<\/strong>fins a\u00a0<strong>l\u2019estat de supervivent<\/strong>. L\u2019activitat, amb una metodologia din\u00e0mica i participativa, va rebre una\u00a0<strong>valoraci\u00f3 molt positiva dels alumnes.<\/strong><\/p>\n<p><strong>El pacient oncol\u00f2gic i l\u2019actuaci\u00f3 farmac\u00e8utica<\/strong><\/p>\n<p>\u201cEl curs suposa una\u00a0<strong>oportunitat \u00fanica<\/strong>\u00a0<strong>per tenir una visi\u00f3 global del tr\u00e0nsit que fa el pacient pels diferents \u00e0mbits assistencials<\/strong>\u00a0i proporciona\u00a0<strong>recursos perqu\u00e8 els farmac\u00e8utics puguem millorar la qualitat de vida dels pacients oncol\u00f2gics\u201d<\/strong>, explica\u00a0<strong>Guillermo Bagaria,\u00a0<\/strong>responsable d\u2019Atenci\u00f3 Farmac\u00e8utica i vicetresorer del COFB, i\u00a0<strong>un dels coordinadors de la formaci\u00f3 juntament amb Cristina Roure,\u00a0<\/strong>vocal d\u2019Hospitals del COFB i presidenta de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), i la<strong>\u00a0Dra. Angels Arcusa,<\/strong>\u00a0cap del Servei d\u2019Oncologia del Consorci Sanitari de Terrassa i Secret\u00e0ria de la Junta de la Societat Catalana d\u2019Oncologia.<\/p>\n<p>Roure destaca que \u201ccada any hi haur\u00e0 100.000 nous llargs supervivents de c\u00e0ncer i que la xifra es doblar\u00e0 l\u2019any 2035\u201d.\u00a0<strong>\u201c<\/strong><strong>Les persones que han sobreviscut a un c\u00e0ncer reprenen les seves\u00a0 vides m\u00e9s lligades<\/strong>\u00a0<strong>al seu entorn,<\/strong>\u00a0a casa seva, al seu barri\u00a0<strong>i als<\/strong>\u00a0<strong>professionals sanitaris m\u00e9s propers, com ara el seu equip de medicina de fam\u00edlia o el seu farmac\u00e8utic de confian\u00e7a<\/strong>.\u00a0<strong>L\u2019<\/strong><strong>atenci\u00f3 farmac\u00e8utica ha d\u2019estar basada en el coneixement\u00a0<\/strong>i, per aix\u00f2,\u00a0<strong>vam pensar en la conveni\u00e8ncia de fer un curs com aquest\u201d,\u00a0<\/strong>concreta la vocal d\u2019Hospitals del COFB. \u00a0<\/p>\n<p>&#8220;L\u2019atenci\u00f3 del pacient amb c\u00e0ncer en tractament o durant el seu seguiment despr\u00e9s de superar la malaltia \u00e9s una tasca complexa caracteritzada per la multidisciplinarietat i en l\u2019equip d\u2019atenci\u00f3 pren un rol singularment molt important el farmac\u00e8utic,\u00a0un professional, sovint un amic, molt a prop del pacient i la seva fam\u00edlia\u201d,\u00a0 exposa la cap del Servei d\u2019Oncologia del Consorci Sanitari de Terrassa. I afegeix: \u201cGr\u00e0cies a aquest curs, s\u2019ha aprofundit en el coneixement del c\u00e0ncer amb una perspectiva transversal centrada en el pacient i el seu entorn\u201d.<\/p>\n<p><strong>El programa del curs<\/strong><\/p>\n<p>El programa del curs constava de tres m\u00f2duls. El primer, titulat\u00a0<strong>\u201cIntroducci\u00f3 i tractament espec\u00edfic del c\u00e0ncer\u201d<\/strong>, va incloure aspectes com les\u00a0<strong>causes de la malaltia<\/strong>\u00a0i la\u00a0<strong>incid\u00e8ncia<\/strong>\u00a0a Catalunya i el m\u00f3n. D\u2019altra banda, tamb\u00e9 es va fer refer\u00e8ncia a la\u00a0<strong>prevenci\u00f3<\/strong>\u00a0a trav\u00e9s de la promoci\u00f3 d\u2019<strong>h\u00e0bits saludables\u00a0<\/strong>i a les\u00a0<strong>campanyes de detecci\u00f3 preco\u00e7\u00a0<\/strong>i\u00a0<strong>programes de cribratge<\/strong>. Per \u00faltim, es va tractar el\u00a0<strong>diagn\u00f2stic\u00a0<\/strong>i les tend\u00e8ncies actuals dels<strong>\u00a0tractaments no farmacol\u00f2gics<\/strong>\u00a0i\u00a0<strong>farmacol\u00f2gics<\/strong>.<\/p>\n<p>Al segon m\u00f2dul,\u00a0<strong>\u201cOportunitats d\u2019atenci\u00f3 farmac\u00e8utica en la detecci\u00f3 i l\u2019abordatge dels efectes secundaris i les seq\u00fceles del tractament\u201d<\/strong>, es va abordar l\u2019<strong>entorn psicosocial i emocional\u00a0<\/strong>del pacient amb c\u00e0ncer. A m\u00e9s, es va incidir en els principals s\u00edmptomes dels\u00a0<strong>efectes secundaris<\/strong>\u00a0relacionats amb l\u2019aparell digestiu, els sistemes cardiovascular i nervi\u00f3s, i la pell i les mucoses. Tamb\u00e9 es va fer refer\u00e8ncia al\u00a0<strong>paper de l\u2019alimentaci\u00f3<\/strong>\u00a0i l\u2019<strong>activitat f\u00edsica<\/strong>.<\/p>\n<p>Finalment, durant l\u2019\u00faltim m\u00f2dul, es va aprofundir en les\u00a0<strong>interaccions del tractament oncol\u00f2gic<\/strong>amb el tractament d\u2019altres patologies, aliments o fitoter\u00e0pia. A m\u00e9s, tamb\u00e9 va haver-hi un espai dedicat a la salut integrativa i el paper de les ter\u00e0pies complement\u00e0ries.<\/p>\n<p>\u00a0<strong>Amb el patrocini de:<\/strong><\/p>\n\n<p>\u00a0<\/p>\n<p>\t<strong><\/strong><strong>Si voleu ampliar continguts, podeu consultar\u00a0<\/strong><strong><a href=\"http:\/\/www.cofb.org\/web\/guest\/cursos?p_p_id=portletllistatactivitats_WAR_portletllistatactivitats_INSTANCE_Au9v&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_col_id=column-2&amp;p_p_col_pos=1&amp;p_p_col_count=2&amp;_portletllistatactivitats_WAR_portletllistatactivitats_INSTANCE_Au9v_strutsAction=%2Fview%2Fdetall&amp;_portletllistatactivitats_WAR_portletllistatactivitats_INSTANCE_Au9v_id=2159\" target=\"_blank\" rel=\"noopener\"><strong>aqu\u00ed<\/strong><\/a>\u00a0<\/strong><strong>la fitxa i el v\u00eddeo del curs.\u00a0<\/strong><\/p>\n<p><strong>Per a m\u00e9s informaci\u00f3:<\/strong><\/p>\n<p>Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/p>\n<p>Tel\u00e8fon: 93 244 07 28 \/ 18\u00a0<\/p>\n<p>premsa@cofb.net<\/p>\n<p>\u00a0Els farmac\u00e8utics han pogut aprofundir coneixements sobre com ajudar els pacients oncol\u00f2gics\u00a0en les diverses fases de la malaltia, des de la prevenci\u00f3 fins a l\u2019estat de supervivent<br \/>\n\tLa formaci\u00f3,\u00a0organitzada per primera vegada pel COF de Barcelona,\u00a0va comptar amb un\u00a0equip multidisciplinari -onc\u00f2legs, farmac\u00e8utics i metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i Equips de Suport (PADES)-\u00a0i els\u00a0alumnes\u00a0en van fer una\u00a0valoraci\u00f3 molt positiva<\/p>\n<p>Els farmac\u00e8utics,\u00a0com a professionals sanitaris propers i de refer\u00e8ncia,\u00a0tenen un paper clau a l\u2019hora d\u2019ajudar al pacient amb c\u00e0ncer a millorar la qualitat de vida i l\u2019adher\u00e8ncia als tractaments.\u00a0Per tal de donar m\u00e9s eines a aquests professionals sanitaris, el\u00a0Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) ha organitzat, per primera vegada,\u00a0un\u00a0curs centrat en l\u2019atenci\u00f3 farmac\u00e8utica a pacients oncol\u00f2gics,\u00a0amb la col\u00b7laboraci\u00f3 de la\u00a0Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC).<\/p>\n<p>La formaci\u00f3,\u00a0impartida per un equip multidisciplinari\u00a0-onc\u00f2legs,\u00a0farmac\u00e8utics\u00a0i\u00a0metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i Equips de Suport (PADES)-, va estar patrocinada per Janssen, Roche i Pfizer. Durant els tres dies que va durar, els\u00a077 farmac\u00e8utics que van assistir \u00a0van aprofundir coneixements sobre com abordar l\u2019actuaci\u00f3 farmac\u00e8utica en totes les etapes del pacient oncol\u00f2gic:\u00a0des de la\u00a0prevenci\u00f3, la\u00a0detecci\u00f3\u00a0i les\u00a0etapes interm\u00e8dies de tractament\u00a0actiu\u00a0fins a\u00a0l\u2019estat de supervivent. L\u2019activitat, amb una metodologia din\u00e0mica i participativa, va rebre una\u00a0valoraci\u00f3 molt positiva dels alumnes.<\/p>\n<p>El pacient oncol\u00f2gic i l\u2019actuaci\u00f3 farmac\u00e8utica<\/p>\n<p>\u201cEl curs suposa una\u00a0oportunitat \u00fanica\u00a0per tenir una visi\u00f3 global del tr\u00e0nsit que fa el pacient pels diferents \u00e0mbits assistencials\u00a0i proporciona\u00a0recursos perqu\u00e8 els farmac\u00e8utics puguem millorar la qualitat de vida dels pacients oncol\u00f2gics\u201d, explica\u00a0Guillermo Bagaria,\u00a0responsable d\u2019Atenci\u00f3 Farmac\u00e8utica i vicetresorer del COFB, i\u00a0un dels coordinadors de la formaci\u00f3 juntament amb Cristina Roure,\u00a0vocal d\u2019Hospitals del COFB i presidenta de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), i la\u00a0Dra. Angels Arcusa,\u00a0cap del Servei d\u2019Oncologia del Consorci Sanitari de Terrassa i Secret\u00e0ria de la Junta de la Societat Catalana d\u2019Oncologia.<\/p>\n<p>Roure destaca que \u201ccada any hi haur\u00e0 100.000 nous llargs supervivents de c\u00e0ncer i que la xifra es doblar\u00e0 l\u2019any 2035\u201d.\u00a0\u201cLes persones que han sobreviscut a un c\u00e0ncer reprenen les seves\u00a0 vides m\u00e9s lligades\u00a0al seu entorn,\u00a0a casa seva, al seu barri\u00a0i als\u00a0professionals sanitaris m\u00e9s propers, com ara el seu equip de medicina de fam\u00edlia o el seu farmac\u00e8utic de confian\u00e7a.\u00a0L\u2019atenci\u00f3 farmac\u00e8utica ha d\u2019estar basada en el coneixement\u00a0i, per aix\u00f2,\u00a0vam pensar en la conveni\u00e8ncia de fer un curs com aquest\u201d,\u00a0concreta la vocal d\u2019Hospitals del COFB. \u00a0<\/p>\n<p>&#8220;L\u2019atenci\u00f3 del pacient amb c\u00e0ncer en tractament o durant el seu seguiment despr\u00e9s de superar la malaltia \u00e9s una tasca complexa caracteritzada per la multidisciplinarietat i en l\u2019equip d\u2019atenci\u00f3 pren un rol singularment molt important el farmac\u00e8utic,\u00a0un professional, sovint un amic, molt a prop del pacient i la seva fam\u00edlia\u201d,\u00a0 exposa la cap del Servei d\u2019Oncologia del Consorci Sanitari de Terrassa. I afegeix: \u201cGr\u00e0cies a aquest curs, s\u2019ha aprofundit en el coneixement del c\u00e0ncer amb una perspectiva transversal centrada en el pacient i el seu entorn\u201d.<\/p>\n<p>El programa del curs<\/p>\n<p>El programa del curs constava de tres m\u00f2duls. El primer, titulat\u00a0\u201cIntroducci\u00f3 i tractament espec\u00edfic del c\u00e0ncer\u201d, va incloure aspectes com les\u00a0causes de la malaltia\u00a0i la\u00a0incid\u00e8ncia\u00a0a Catalunya i el m\u00f3n. D\u2019altra banda, tamb\u00e9 es va fer refer\u00e8ncia a la\u00a0prevenci\u00f3\u00a0a trav\u00e9s de la promoci\u00f3 d\u2019h\u00e0bits saludables\u00a0i a les\u00a0campanyes de detecci\u00f3 preco\u00e7\u00a0i\u00a0programes de cribratge. Per \u00faltim, es va tractar el\u00a0diagn\u00f2stic\u00a0i les tend\u00e8ncies actuals dels\u00a0tractaments no farmacol\u00f2gics\u00a0i\u00a0farmacol\u00f2gics.<\/p>\n<p>Al segon m\u00f2dul,\u00a0\u201cOportunitats d\u2019atenci\u00f3 farmac\u00e8utica en la detecci\u00f3 i l\u2019abordatge dels efectes secundaris i les seq\u00fceles del tractament\u201d, es va abordar l\u2019entorn psicosocial i emocional\u00a0del pacient amb c\u00e0ncer. A m\u00e9s, es va incidir en els principals s\u00edmptomes dels\u00a0efectes secundaris\u00a0relacionats amb l\u2019aparell digestiu, els sistemes cardiovascular i nervi\u00f3s, i la pell i les mucoses. Tamb\u00e9 es va fer refer\u00e8ncia al\u00a0paper de l\u2019alimentaci\u00f3\u00a0i l\u2019activitat f\u00edsica.<\/p>\n<p>Finalment, durant l\u2019\u00faltim m\u00f2dul, es va aprofundir en les\u00a0interaccions del tractament oncol\u00f2gicamb el tractament d\u2019altres patologies, aliments o fitoter\u00e0pia. A m\u00e9s, tamb\u00e9 va haver-hi un espai dedicat a la salut integrativa i el paper de les ter\u00e0pies complement\u00e0ries.<\/p>\n<p>\u00a0Amb el patrocini de:<\/p>\n<p>\u00a0<\/p>\n<p>\tSi voleu ampliar continguts, podeu consultar\u00a0aqu\u00ed\u00a0la fitxa i el v\u00eddeo del curs.\u00a0<\/p>\n<p>Per a m\u00e9s informaci\u00f3:<\/p>\n<p>Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/p>\n<p>Tel\u00e8fon: 93 244 07 28 \/ 18\u00a0<\/p>\n<p>premsa@cofb.net\u00a0\u00a0COFB.ORG<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a0 Els farmac\u00e8utics han pogut aprofundir coneixements sobre com ajudar els pacients oncol\u00f2gics\u00a0en les diverses fases de la malaltia, des de la prevenci\u00f3 fins a l\u2019estat de supervivent La formaci\u00f3,\u00a0organitzada per primera vegada pel COF de Barcelona,\u00a0va comptar amb un\u00a0equip multidisciplinari -onc\u00f2legs, farmac\u00e8utics i metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77940","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#039;atenci\u00f3 a pacients amb c\u00e0ncer - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#039;atenci\u00f3 a pacients amb c\u00e0ncer - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 Els farmac\u00e8utics han pogut aprofundir coneixements sobre com ajudar els pacients oncol\u00f2gics\u00a0en les diverses fases de la malaltia, des de la prevenci\u00f3 fins a l\u2019estat de supervivent La formaci\u00f3,\u00a0organitzada per primera vegada pel COF de Barcelona,\u00a0va comptar amb un\u00a0equip multidisciplinari -onc\u00f2legs, farmac\u00e8utics i metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-12T12:34:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#8217;atenci\u00f3 a pacients amb c\u00e0ncer\",\"datePublished\":\"2018-06-12T12:34:00+00:00\",\"dateModified\":\"2018-06-12T12:34:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\"},\"wordCount\":1723,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\",\"name\":\"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l'atenci\u00f3 a pacients amb c\u00e0ncer - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2018-06-12T12:34:00+00:00\",\"dateModified\":\"2018-06-12T12:34:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#8217;atenci\u00f3 a pacients amb c\u00e0ncer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l'atenci\u00f3 a pacients amb c\u00e0ncer - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/","og_locale":"ca_ES","og_type":"article","og_title":"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l'atenci\u00f3 a pacients amb c\u00e0ncer - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 Els farmac\u00e8utics han pogut aprofundir coneixements sobre com ajudar els pacients oncol\u00f2gics\u00a0en les diverses fases de la malaltia, des de la prevenci\u00f3 fins a l\u2019estat de supervivent La formaci\u00f3,\u00a0organitzada per primera vegada pel COF de Barcelona,\u00a0va comptar amb un\u00a0equip multidisciplinari -onc\u00f2legs, farmac\u00e8utics i metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2018-06-12T12:34:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"9 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#8217;atenci\u00f3 a pacients amb c\u00e0ncer","datePublished":"2018-06-12T12:34:00+00:00","dateModified":"2018-06-12T12:34:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/"},"wordCount":1723,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/","url":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/","name":"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l'atenci\u00f3 a pacients amb c\u00e0ncer - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2018-06-12T12:34:00+00:00","dateModified":"2018-06-12T12:34:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2018\/06\/12\/farmaceutics-de-barcelona-es-formen-per-tenir-mes-eines-en-latencio-a-pacients-amb-cancer-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Farmac\u00e8utics de Barcelona es formen per tenir m\u00e9s eines en l&#8217;atenci\u00f3 a pacients amb c\u00e0ncer"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 Els farmac\u00e8utics han pogut aprofundir coneixements sobre com ajudar els pacients oncol\u00f2gics\u00a0en les diverses fases de la malaltia, des de la prevenci\u00f3 fins a l\u2019estat de supervivent La formaci\u00f3,\u00a0organitzada per primera vegada pel COF de Barcelona,\u00a0va comptar amb un\u00a0equip multidisciplinari -onc\u00f2legs, farmac\u00e8utics i metges del Programa d\u2019Atenci\u00f3 Domicili\u00e0ria i [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77940"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77940\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}